Israel Plasma Protein Therapeutics Market (2025-2031) | Analysis, Value, Companies, Segmentation, Size & Revenue, Competitive Landscape, Industry, Growth, Forecast, Share, Trends, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Plasma Protein Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Israel Plasma Protein Therapeutics Market - Industry Life Cycle

3.4 Israel Plasma Protein Therapeutics Market - Porter's Five Forces

3.5 Israel Plasma Protein Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 Israel Plasma Protein Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases such as hemophilia, immune deficiencies, and neurological disorders in Israel.

4.2.2 Growing awareness and adoption of plasma protein therapeutics among healthcare professionals and patients.

4.2.3 Technological advancements in plasma fractionation techniques leading to the development of novel therapies.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the approval and commercialization of plasma protein therapeutics.

4.3.2 High cost associated with plasma protein therapies, limiting affordability for some patients.

4.3.3 Limited availability of plasma donors and challenges in ensuring a stable and sustainable supply chain for plasma proteins.

6.1 Israel Plasma Protein Therapeutics Market, By Product

6.1.1 Overview and Analysis

6.1.2 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Albumin, 2021- 2031F

6.1.4 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Immunoglobulin, 2021- 2031F

6.1.5 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Plasma-derived Factor VIII, 2021- 2031F

6.1.6 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Plasma Protein Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Hemophilia, 2021- 2031F

6.2.3 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Primary Immunodeficiency Disorder (PIDD), 2021- 2031F

6.2.4 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura (ITP), 2021- 2031F

6.2.5 Israel Plasma Protein Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

7.1 Israel Plasma Protein Therapeutics Market Export to Major Countries

7.2 Israel Plasma Protein Therapeutics Market Imports from Major Countries

8.1 Patient adherence rates to plasma protein therapies.

8.2 Number of clinical trials and research studies focused on plasma protein therapeutics in Israel.

8.3 Rate of adoption of new plasma protein therapies by healthcare facilities in Israel.

9.1 Israel Plasma Protein Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 Israel Plasma Protein Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 Israel Plasma Protein Therapeutics Market Revenue Share, By Companies, 2024

10.2 Israel Plasma Protein Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters